International Standards

    LASIK Safety: Global Guidelines & Regulatory Standards

    Every LASIK procedure at Centre for Lasik follows guidelines set by the world's top regulatory and medical bodies — FDA, WHO, AAO, ESCRS, AIOS, and NICE. Here's what these organizations say about the safety, efficacy, and standards of modern laser eye surgery.

    99.5%

    Patient Satisfaction Rate (FDA PROWL Study)

    40M+

    LASIK Procedures Performed Globally

    25+ Years

    Track Record Since FDA Approval (1999)

    <0.1%

    Serious Complication Rate

    Book Free Consultation

    Get a callback within 30 minutes

    Protected by reCAPTCHA. Google Privacy & Terms apply.

    What Global Authorities Say About LASIK

    Evidence-based guidelines from six leading regulatory and medical organizations worldwide

    US FDA (Food & Drug Administration)

    United States

    The US FDA approved LASIK in 1999 and classifies excimer lasers as Class III medical devices. FDA mandates pre-market approval (PMA) for all laser platforms, rigorous clinical trials with 6–12 month follow-ups, adverse event reporting (MedWatch), and informed consent disclosures. The FDA's LASIK Quality of Life Collaboration Study (2014) confirmed 95.4% patient satisfaction.

    All laser devices require PMA with extensive clinical trial data
    Minimum age: 18 years; stable prescription for 12 months
    Mandatory adverse event reporting through MedWatch system
    Post-market surveillance studies required for all approved devices
    FDA-approved platforms: WaveLight EX500, VisuMax 800, elita™, MEL 90
    Official Source

    WHO (World Health Organization)

    Global

    The WHO recognizes refractive error as a leading cause of visual impairment affecting 2.7 billion people globally. WHO's Vision 2020 initiative includes refractive correction through spectacles, contact lenses, and refractive surgery as key interventions. WHO recommends that refractive surgery be performed by trained ophthalmologists in accredited facilities with proper equipment.

    Refractive error is the #1 cause of correctable visual impairment worldwide
    Refractive surgery included in Vision 2020: The Right to Sight initiative
    Recommends surgery only by qualified ophthalmologists in accredited facilities
    Emphasizes informed consent and patient counseling before surgery
    Supports accessibility of refractive correction in developing nations
    Official Source

    AAO (American Academy of Ophthalmology)

    United States

    The AAO publishes Preferred Practice Patterns (PPP) for refractive surgery, updated every 3–5 years. The AAO recommends comprehensive pre-operative evaluation including corneal topography, pachymetry, wavefront analysis, and dry eye assessment. AAO guidelines specify minimum residual stromal bed thickness of 250μm and recommend against surgery in patients with keratoconus or unstable prescriptions.

    Preferred Practice Patterns updated every 3–5 years with latest evidence
    Minimum residual stromal bed: 250μm after ablation
    Contraindicated in keratoconus, autoimmune disorders, uncontrolled diabetes
    Pre-op must include topography, pachymetry, wavefront, and dry eye evaluation
    Surgeon must have completed fellowship-level training in refractive surgery
    Official Source

    ESCRS (European Society of Cataract and Refractive Surgeons)

    Europe

    ESCRS provides evidence-based clinical guidelines and conducts the largest annual refractive surgery survey in Europe. ESCRS guidelines emphasize topography-guided treatments (like Contoura Vision) for superior visual outcomes, validate lenticule extraction (SMILE/SiLK) as equivalent to LASIK for myopia, and recommend femtosecond laser flap creation over microkeratome for improved safety.

    Endorses topography-guided ablation for best visual quality outcomes
    Validates SMILE/lenticule extraction as equivalent to LASIK for myopia correction
    Recommends femtosecond laser flap creation over mechanical microkeratome
    Annual survey tracks outcomes from 500,000+ procedures across Europe
    Guidelines available for surgeon certification and facility accreditation
    Official Source

    AIOS (All India Ophthalmological Society)

    India

    AIOS, with 20,000+ members, sets national standards for refractive surgery in India. AIOS guidelines align with international standards while addressing India-specific considerations like higher astigmatism prevalence, thinner corneas in Indian populations, and tropical climate considerations for post-op care. AIOS recommends Contoura/topography-guided treatments for Indian patients with high astigmatism.

    Guidelines address Indian-specific corneal parameters (thinner average corneas)
    Recommends topography-guided treatments for higher astigmatism prevalence
    Post-op protocols account for tropical climate and dust exposure
    Mandatory NABH accreditation for centres performing refractive surgery
    Annual National Refractive Surgery Survey for outcome benchmarking
    Official Source

    NICE (National Institute for Health and Care Excellence)

    United Kingdom

    NICE evaluates refractive surgery technologies for the UK's NHS. NICE Interventional Procedures Guidance (IPG) covers LASIK (IPG164), SMILE (IPG616), and surface ablation (IPG164). NICE confirms that LASIK is safe and efficacious for myopia, hyperopia, and astigmatism, and has classified SMILE as a safe alternative to LASIK for myopia.

    IPG164: LASIK is safe and efficacious — normal arrangements for consent apply
    IPG616: SMILE is safe for myopia — no special safety concerns
    Recommends audit of patient outcomes by all refractive surgery providers
    Informed consent must cover alternatives, risks, and realistic expectations
    Supports shared decision-making between surgeon and patient
    Official Source

    How Centre for Lasik Meets Global Standards

    Our commitment to exceeding international safety benchmarks

    FDA-Approved Platforms Only

    We use only FDA-approved laser systems: WaveLight EX500/EX800, Carl Zeiss VisuMax 800, and J&J elita™ — no off-brand devices.

    AAO Pre-Op Protocol

    Our free 90-minute diagnostic follows AAO Preferred Practice Patterns: Pentacam, topography, pachymetry, wavefront, dry eye assessment.

    ESCRS Outcome Tracking

    Every patient's outcomes are tracked and benchmarked against ESCRS annual survey data for quality assurance.

    AIOS-Compliant Facility

    All centres meet AIOS and NABH accreditation standards with climate-controlled surgical suites and laminar airflow.

    WHO-Aligned Access

    Starting at ₹8,999/eye with EMI from ₹750/month — making vision correction accessible per WHO Vision 2020 goals.

    NICE Informed Consent

    We follow NICE shared decision-making guidelines with comprehensive written consent, realistic expectations, and alternative options.

    International LASIK Guidelines — FAQ

    Common questions about LASIK safety standards and regulations

    Your Eyes Deserve Global-Standard Care

    Book a free consultation and experience LASIK that meets FDA, WHO, and AAO guidelines.